Denali Therapeutics Inc. is seeking a senior DMPK leader to head the Nonclinical Safety Assessment and DMPK group, providing strategic vision for PK, drug disposition, and translational pharmacology across discovery to early clinical development.
You will guide SME-level decision-making, mentor staff, and collaborate with cross-functional teams to shape study designs and regulatory submissions. The role emphasizes leading cross-functional Project Teams, directing TK analyses for non-GLP/GLP
#J-18808-LjbffrDirector, DMPK & Translational PK Strategy in south san francisco at Unknown Company
This position is listed as full time and onsite.